Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma

被引：3
|
作者：
Noorduyn, Stephen G. [1 ,2 ]
Johnston, Karissa [3 ,4 ]
Osenenko, Kathy [3 ]
Sriskandarajah, Niroshan [1 ]
Gendron, Alain [5 ]
Mbuagbaw, Lawrence [2 ]
机构：
[1] AstraZeneca Canada Ltd, Mississauga, ON, Canada
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[3] Broadstreet HEOR, Vancouver, BC, Canada
[4] Mem Univ, St John, NF, Canada
[5] Univ Montreal, Dept Med, Montreal, PQ, Canada
来源：
ERJ OPEN RESEARCH | 2021年 / 7卷 / 04期
关键词：
D O I：
10.1183/23120541.00465-2021
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] TOTAL NASAL SYMPTOM SCORE IMPROVEMENT WITH BENRALIZUMAB FOR PATIENTS WITH SEVERE, EOSINOPHILIC ASTHMA
    Chipps, B.
    Corren, J.
    Israel, E.
    Barker', P.
    Kreindler, J.
    Newbold, P.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S24 - S24
  • [32] Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis
    Canonica, Giorgio Walter
    Harrison, Tim W.
    Chanez, Pascal
    Menzella, Francesco
    Louis, Renaud
    Cosio, Borja G.
    Lugogo, Njira L.
    Mohan, Arjun
    Burden, Annie
    Gil, Esther Garcia
    [J]. ALLERGY, 2022, 77 (01) : 150 - 161
  • [33] Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
    Scioscia, Giulia
    Tondo, Pasquale
    Nolasco, Santi
    Pelaia, Corrado
    Carpagnano, Giovanna Elisiana
    Caiaffa, Maria Filomena
    Valenti, Giuseppe
    Maglio, Angelantonio
    Papia, Francesco
    Triggiani, Massimo
    Crimi, Nunzio
    Pelaia, Girolamo
    Vatrella, Alessandro
    Barbaro, Maria Pia Foschino
    Crimi, Claudia
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [34] Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab
    Hocevar, Alojzija
    Kopac, Peter
    Rotar, Ziga
    Novljan, Martina Plesivcnik
    Skrgat, Sabina
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (07): : 2448 - 2449
  • [35] REAL-LIFE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA WITH BENRALIZUMAB
    Pelaia, C.
    Busceti, M. T.
    Vatrella, A.
    Rago, G. F.
    Crimi, C.
    Pelaia, G.
    [J]. CHEST, 2020, 157 (06) : 6A - 6A
  • [36] Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
    Kavanagh, Joanne E.
    Hearn, Andrew P.
    Dhariwal, Jaideep
    d'Ancona, Grainne
    Douiri, Abdel
    Roxas, Cris
    Fernandes, Mariana
    Green, Linda
    Thomson, Louise
    Nanzer, Alexandra M.
    Kent, Brian D.
    Jackson, David J.
    [J]. CHEST, 2021, 159 (02) : 496 - 506
  • [37] Severe eosinophilic asthma: remission with add-on therapy with benralizumab
    Hofmann-Assmus, Marion
    [J]. ALLERGO JOURNAL, 2023, 32 (05) : 51 - 51
  • [38] Benralizumab strongly reduces blood basophils in severe eosinophilic asthma
    Lommatzsch, Marek
    Marchewski, Hannes
    Schwefel, Georg
    Stoll, Paul
    Virchow, Johann Christian
    Bratke, Kai
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2020, 50 (11): : 1267 - 1269
  • [39] CLINICAL EFFICACY CHARACTERIZATION OF BENRALIZUMAB FOR PATIENTS WITH NASAL POLYPOSIS AND SEVERE, UNCONTROLLED EOSINOPHILIC ASTHMA
    Katial, R.
    Siddiqui, S.
    Barker, P.
    Kwiatek, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S26 - S26
  • [40] Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
    Numata, Takanori
    Miyagawa, Hanae
    Nishioka, Saiko
    Okuda, Keitaro
    Utsumi, Hirofumi
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Araya, Jun
    Kuwano, Kazuyoshi
    [J]. BMC PULMONARY MEDICINE, 2020, 20 (01)
12345